8-K Current report filing
- Filed
- Period
- Accession number
- 0001213900-26-050249
Documents
- CURRENT REPORT 8-K
- UNDERWRITING AGREEMENT BY AND AMONG ORUKA THERAPEUTICS, INC. AND LEERINK PARTNERS LLC, TD SECURITIES (USA) LLC, GOLDMAN SACHS & CO. LLC, STIFEL, NICOLAUS & COMPANY EX-1.1
- OPINION OF DAVIS POLK & WARDWELL LLP EX-5.1
- EXCERPT FROM PRELIMINARY PROSPECTUS SUPPLEMENT DATED APRIL 27, 2026 EX-99.1
- XBRL SCHEMA FILE EX-101.SCH
- XBRL LABEL FILE EX-101.LAB
- XBRL PRESENTATION FILE EX-101.PRE